Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Imaging and Biology
Published in: Molecular Imaging and Biology 5/2017

01-10-2017 | Review Article

Fluorescence Imaging for Cancer Screening and Surveillance

Authors: K. E. Tipirneni, E. L. Rosenthal, L. S. Moore, A. D. Haskins, N. Udayakumar, A. H. Jani, W. R. Carroll, A. B. Morlandt, M. Bogyo, J. Rao, Jason M. Warram

Published in: Molecular Imaging and Biology | Issue 5/2017

Login to get access

Abstract

The advent of fluorescence imaging (FI) for cancer cell detection in the field of oncology is promising for both cancer screening and surgical resection. Particularly, FI in cancer screening and surveillance is actively being evaluated in many new clinical trials with over 30 listed on Clinical Trials.​gov. While surgical resection forms the foundation of many oncologic treatments, early detection is the cornerstone for improving outcomes and reducing cancer-related morbidity and mortality. The applications of FI are twofold as it can be applied to high-risk patients in addition to those undergoing active surveillance. This technology has the promise of highlighting lesions not readily detected by conventional imaging or physical examination, allowing disease detection at an earlier stage of development. Additionally, there is a persistent need for innovative, cost-effective imaging modalities to ameliorate healthcare disparities and the global burden of cancer worldwide. In this review, we outline the current utility of FI for screening and detection in a range of cancer types.
Literature
1.
Tsu VD, Jeronimo J, Anderson BO (2013) Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ 91:683–690CrossRefPubMedPubMedCentral
2.
3.
Joshi BP, Duan X, Kwon RS et al (2016) Multimodal endoscope can quantify wide-field fluorescence detection of Barrett's neoplasia. Endoscopy 48:A1–A13CrossRefPubMed
4.
Smith RA, Cokkinides V, Eyre HJ (2006) American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56:11–25 quiz 49-50CrossRefPubMed
5.
6.
Chesson HW, Dunne EF, Hariri S, Markowitz LE (2014) The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis 41:660–664CrossRefPubMed
7.
8.
Ferlay JSI, Ervik M, Dikshit R, et al. (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013
9.
Bychkovsky BL, Ferreyra ME, Strasser-Weippl K et al (2016) Cervical cancer control in Latin America: a call to action. Cancer 122:502–514CrossRefPubMed
10.
Julius JM, Ramondeta L, Tipton KA et al (2011) Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer. Pharmacotherapy 31:280–297CrossRefPubMed
11.
Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R (2013) Screening for cervical cancer: a systematic review and meta-analysis. Systematic reviews 2:35CrossRefPubMedPubMedCentral
12.
Grant BD, Schwarz RA, Quang T et al (2015) High-resolution microendoscope for the detection of cervical neoplasia. Methods Mol Biol 1256:421–434CrossRefPubMed
13.
Pierce MC, Guan Y, Quinn MK et al (2012) A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer. Cancer Prev Res (Phila) 5:1273–1279CrossRef
14.
Cronje HS, Parham GP, Cooreman BF et al (2003) A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol 188:395–400CrossRefPubMed
15.
Thekkek N, Richards-Kortum R (2008) Optical imaging for cervical cancer detection: solutions for a continuing global problem. Nat Rev Cancer 8:725–731CrossRefPubMedPubMedCentral
16.
Bedard N, Schwarz RA, Hu A et al (2013) Multimodal snapshot spectral imaging for oral cancer diagnostics: a pilot study. Biomed Opt Express 4:938–949CrossRefPubMedPubMedCentral
17.
American Cancer Society (2016) Cancer Facts & Figures 2016. American Cancer Society, Atlanta
18.
19.
Moore SR, Johnson NW, Pierce AM, Wilson DF (2000) The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6:65–74CrossRefPubMed
20.
Schwarz RA, Gao W, Redden Weber C et al (2009) Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy. Cancer 115:1669–1679CrossRefPubMedPubMedCentral
21.
National Comprehensive Cancer Network Guidelines. Head and Neck Cancers. Version 2.2013. NCCN.​org. Accessed 29 Aug 2016.
22.
Pierce MC, Schwarz RA, Bhattar VS et al (2012) Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia. Cancer Prev Res (Phila) 5:801–809CrossRef
23.
Lane PM, Gilhuly T, Whitehead P et al (2006) Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 11:024006CrossRefPubMed
24.
Sweeny L, Dean NR, Magnuson JS et al (2011) Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. Otolaryngology—head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery 145:956–960CrossRef
25.
Lalla Y, Matias MA, Farah CS (2016) Assessment of oral mucosal lesions with autofluorescence imaging and reflectance spectroscopy. J Am Dent Assoc 147:650–660CrossRefPubMed
26.
Houghton O, McCluggage WG (2009) The expression and diagnostic utility of p63 in the female genital tract. Adv Anat Pathol 16:316–321CrossRefPubMed
27.
Pawinski A, Sylvester R, Kurth KH et al (1996) A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urology 156:1934–1940 discussion 1940-1931CrossRef
28.
Thomas F, Noon AP, Rubin N et al (2013) Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer. Eur Urology 63:145–154CrossRef
29.
Botteman MF, Pashos CL, Redaelli A et al (2003) The health economics of bladder cancer: a comprehensive review of the published literature. PharmacoEconomics 21:1315–1330CrossRefPubMed
30.
Rink M, Babjuk M, Catto JW et al (2013) Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urology 64:624–638CrossRef
31.
Zaak D, Kriegmair M, Stepp H et al (2001) Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 57:690–694CrossRefPubMed
32.
Jichlinski P, Forrer M, Mizeret J et al (1997) Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 20:402–408CrossRefPubMed
33.
Marti A, Jichlinski P, Lange N et al (2003) Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urology 170:428–432CrossRef
34.
Kausch I, Sommerauer M, Montorsi F et al (2010) Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urology 57:595–606CrossRef
35.
Stenzl A, Penkoff H, Dajc-Sommerer E et al (2011) Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial. Cancer 117:938–947CrossRefPubMed
36.
Jocham D, Witjes F, Wagner S et al (2005) Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urology 174:862–866 discussion 866CrossRef
37.
Schmidbauer J, Witjes F, Schmeller N et al (2004) Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urology 171:135–138CrossRef
38.
Zaak D, Hungerhuber E, Schneede P et al (2002) Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer 95:1234–1238CrossRefPubMed
39.
Pan Y, Volkmer JP, Mach KE et al (2014) Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. Sci Transl Med 6:260ra148CrossRefPubMed
40.
Society AC (2015) Global cancer facts & figures, 3rd edn. American Cancer Society, Atlanta
41.
Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100:1184–1187CrossRefPubMedPubMedCentral
42.
43.
Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146CrossRefPubMed
44.
Solaymani-Dodaran M, Logan RF, West J et al (2004) Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 53:1070–1074CrossRefPubMedPubMedCentral
45.
Kariv R, Plesec TP, Goldblum JR et al (2009) The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol 7:653–658 quiz 606CrossRefPubMed
46.
Freitag CP, Barros SG, Kruel CD et al (1999) Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil. Dis Esophagus 12:191–195CrossRefPubMed
47.
Reddymasu SC, Sharma P (2008) Advances in endoscopic imaging of the esophagus. Gastroenterol Clin N Am 37:763–774 viiCrossRef
48.
Dawsey SM, Fleischer DE, Wang GQ et al (1998) Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 83:220–231CrossRefPubMed
49.
Hashimoto CL, Iriya K, Baba ER et al (2005) Lugol’s dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol 100:275–282CrossRefPubMed
50.
Wei WQ, Abnet CC, Lu N et al (2005) Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut 54:759–763CrossRefPubMedPubMedCentral
51.
Protano MA, Xu H, Wang G et al (2015) Low-cost high-resolution microendoscopy for the detection of esophageal squamous cell neoplasia: an international trial. Gastroenterology 149:321–329CrossRefPubMedPubMedCentral
52.
Winawer SJ, Zauber AG, Ho MN et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup The New England journal of medicine 329:1977–1981CrossRefPubMed
53.
Zauber AG, Winawer SJ, O'Brien MJ et al (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687–696CrossRefPubMedPubMedCentral
54.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefPubMed
55.
Heresbach D, Barrioz T, Lapalus MG et al (2008) Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 40:284–290CrossRefPubMed
56.
Leufkens AM, van Oijen MG, Vleggaar FP, Siersema PD (2012) Factors influencing the miss rate of polyps in a back-to-back colonoscopy study. Endoscopy 44:470–475CrossRefPubMed
57.
Rex DK, Cutler CS, Lemmel GT et al (1997) Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112:24–28CrossRefPubMed
58.
Diamond SJ, Enestvedt BK, Jiang Z et al (2011) Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc 74:135–140CrossRefPubMed
59.
Rabeneck L, Paszat LF, Hilsden RJ et al (2008) Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 135:1899–1906 1906 e1891CrossRefPubMed
60.
Hassan C, Pickhardt PJ, Rex DK (2010) A resect and discard strategy would improve cost-effectiveness of colorectal cancer screening. Clin Gastroenterol Hepatol 8:865–869 869 e861-863CrossRefPubMed
61.
Chang SS, Shukla R, Polydorides AD et al (2013) High resolution microendoscopy for classification of colorectal polyps. Endoscopy 45:553–559CrossRefPubMed
62.
63.
Parikh ND, Perl D, Lee MH et al (2015) In vivo classification of colorectal neoplasia using high-resolution microendoscopy: improvement with experience. J Gastroenterol Hepatol 30:1155–1160CrossRefPubMedPubMedCentral
64.
Zhou J, Joshi BP, Duan X et al (2015) EGFR overexpressed in colonic neoplasia can be detected on wide-field endoscopic imaging. Clin Transl Gastroenterol 6:e101CrossRefPubMedPubMedCentral
65.
Spano JP, Lagorce C, Atlan D et al (2005) Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol 16:102–108CrossRefPubMed
66.
Porebska I, Harlozinska A, Bojarowski T (2000) Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumour Biol 21:105–115CrossRefPubMed
67.
Sano T, Sasako M, Kinoshita T, Maruyama K (1993) Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer 72:3174–3178CrossRefPubMed
68.
Namikawa T, Kobayashi M, Kitagawa H et al (2009) Differentiated adenocarcinoma with a gastric phenotype in the stomach: difficulties in clinical and pathological diagnoses. Clin J Gastroenterol 2:268–274CrossRefPubMed
69.
Okabayashi T, Kobayashi M, Nishimori I et al (2008) Clinicopathological features and medical management of early gastric cancer. Am J Surg 195:229–232CrossRefPubMed
70.
So J, Rajnakova A, Chan YH et al (2013) Endoscopic tri-modal imaging improves detection of gastric intestinal metaplasia among a high-risk patient population in Singapore. Diges Dis Sci 58:3566–3575CrossRef
71.
Namikawa T, Inoue K, Uemura S et al (2014) Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer. J Surg Oncol 109:213–217CrossRefPubMed
72.
73.
Namikawa T, Inoue K, Shuin T, Hanazaki K (2015) Photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid. In: Dip DF, Ishizawa T, Kokudo N, Rosenthal JR (eds) Fluorescence imaging for surgeons: concepts and applications. Springer International Publishing, Cham, pp 195–201CrossRef
74.
Namikawa T, Yatabe T, Inoue K et al (2015) Clinical applications of 5-aminolevulinic acid-mediated fluorescence for gastric cancer. World J Gastroenterol 21:8769–8775CrossRefPubMedPubMedCentral
75.
Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F (2009) Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 41:751–757CrossRefPubMed
76.
Abe S, Oda I, Suzuki H et al (2013) Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy 45:703–707CrossRefPubMed
77.
Rogers HW, Weinstock MA, Harris AR et al (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283–287CrossRefPubMed
78.
Lim L, Nichols B, Migden MR et al (2014) Clinical study of noninvasive in vivo melanoma and nonmelanoma skin cancers using multimodal spectral diagnosis. J Biomed Opt 19:117003CrossRefPubMedPubMedCentral
79.
Howlader NNA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds) (1975-2008) SEER cancer statistics review. National Cancer Institute, Bethesda
80.
Moreno G, Tran H, Chia AL, Lim A, Shumack S (2007) Prospective study to assess general practitioners’ dermatological diagnostic skills in a referral setting. Australas J Dermatol 48:77–82CrossRefPubMed
81.
Tran H, Chen K, Lim AC, Jabbour J, Shumack S (2005) Assessing diagnostic skill in dermatology: a comparison between general practitioners and dermatologists. Australas J Dermatol 46:230–234CrossRefPubMed
82.
Elbaum M, Kopf AW, Rabinovitz HS et al (2001) Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol 44:207–218CrossRefPubMed
83.
Gutkowicz-Krusin D, Elbaum M, Jacobs A et al (2000) Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind(TM) multispectral digital dermoscope. Melanoma Res 10:563–570CrossRefPubMed
84.
Michalska M, Chodorowska G, Krasowska D (2004) SIAscopy—a new non-invasive technique of melanoma diagnosis. Ann Univ Mariae Curie Sklodowska Med 59:421–431PubMed
85.
Patel JK, Konda S, Perez OA et al (2008) Newer technologies/techniques and tools in the diagnosis of melanoma. Eur J Dermatol 18:617–631PubMed
86.
87.
Del Rosal B, Villa I, Jaque D, Sanz-Rodriguez F (2016) In vivo autofluorescence in the biological windows: the role of pigmentation. J Biophotonics 9:1059–1067CrossRefPubMed
88.
Quinn MK, Bubi TC, Pierce MC et al (2012) High-resolution microendoscopy for the detection of cervical neoplasia in low-resource settings. PLoS One 7:e44924CrossRefPubMedPubMedCentral
89.
Daneshmand S, Schuckman AK, Bochner BH et al (2014) Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol 11:589–596PubMed
Metadata
Title
Fluorescence Imaging for Cancer Screening and Surveillance
Authors
K. E. Tipirneni
E. L. Rosenthal
L. S. Moore
A. D. Haskins
N. Udayakumar
A. H. Jani
W. R. Carroll
A. B. Morlandt
M. Bogyo
J. Rao
Jason M. Warram
Publication date
01-10-2017
Publisher
Springer US
Published in
Molecular Imaging and Biology / Issue 5/2017
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-017-1050-5

Other articles of this Issue 5/2017

Molecular Imaging and Biology 5/2017 Go to the issue

Research Article

Quantitative SPM Analysis Involving an Adaptive Template May Be Easily Applied to [18F]FDG PET Images of the Rat Brain

Research Article

Development of a New Folate-Derived Ga-68-Based PET Imaging Agent

Research Article

Development of Diagnostic Techniques for Early Rheumatoid Arthritis Using Positron Emission Tomography with [11C]PK11195 and [11C]Ketoprofen Tracers

Research Article

[68Ga]NOTA-Galactosyl Human Serum Albumin: a Tracer for Liver Function Imaging with Improved Stability

Research Article

A Novel Modality for Functional Imaging in Acute Intervertebral Disk Herniation via Tracking Leukocyte Infiltration

Research Article

Response-Derived Input Function Estimation for Dynamic Contrast-Enhanced MRI Demonstrated by Anti-DLL4 Treatment in a Murine U87 Xenograft Model